Healthcare -
Biotechnology - NASDAQ - US
$ 3.35
0.601 %
$ 2.33 M
Market Cap
0.0
P/E
RNAZ - CASH FROM OPERATIONS
Cash from Operations RNAZ - TransCode Therapeutics, Inc.
-18.1 M
LAST VALUE
-85.25%
2 YEAR CAGR
-127.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR